COMMONWEALTH SERUM LABORATORIES REGULATIONS (AMENDMENT) 1983 NO. 23 

COMMONWEALTH SERUM LABORATORIES REGULATIONS (AMENDMENT) 1983 NO. 23 
- TABLE OF PROVISIONS

1. Prescribed classes of pharmaceutical products  
2.  


1983 No. 23 COMMONWEALTH SERUM LABORATORIES REGULATIONS (AMENDMENT)
- REG 1
Prescribed classes of pharmaceutical products


  1. Regulation 3 of the Commonwealth Serum Laboratories Regulations is
amended by adding at the end thereof the following sub-regulation:
  "(2) Where, but for this sub-regulation, a class of pharmaceutical products
specified in sub-regulation (1) would include a pharmaceutical product
specified in regulation 4 that product is not included in that class.".


1983 No. 23 COMMONWEALTH SERUM LABORATORIES REGULATIONS (AMENDMENT)
- REG 2


  2. The Commonwealth Serum Laboratories Regulations are amended by adding at
the end thereof the following regulation:
Prescribed pharmaceutical products
  "4. The following pharmaceutical products (in any form) are prescribed for
the purposes of paragraph 19 (1) (a) of the Commonwealth Serum Laboratories
Act 1961:
    (a)    amiloride hydrochloride;
    (b)    amitriptyline embonate;
    (c)    amitriptyline hydrochloride;
    (d)    benztropine mesylate;
    (e)    chlorothiazide;
    (f)    cyproheptadine hydrochloride;
    (g)    diflunisal;
    (h)    ethacrynic acid;
    (i)    mixtures of hydrochlorothiazide and amiloride hydrochloride;
    (j)    hydrochlorothiazide;
    (k)    indomethacin;
    (l)    mixtures of levodopa and carbidopa;
    (m)    mecamylamine hydrochloride;
    (n)    methyldopa;
    (o)    prpbenecid;
    (p)    protriptyline hydrochloride;
    (q)    pyrazinamide;
    (r)    sulindac;
    (s)    thiabendazole;     (t)    timolol maleate;     (u)    mixtures of
Vitamin B complex with glycerophosphates.".


- NOTES


1983 No. 23*1* COMMONWEALTH SERUM LABORATORIES REGULATIONS*2* (AMENDMENT)



*1* Notified in the Commonwealth of Australia Gazette on 28 February 1983.
*2* Statutory Rules 1981 No. 7.